- Home
- EQX vs ASND Comparison
EQX vs ASND Comparison
Compare EQX & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EQX | ASND |
|---|---|---|
| Founded | 2007 | 2006 |
| Country | Canada | Denmark |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.3B | 14.7B |
| IPO Year | 2018 | 2014 |
Fundamental Metrics
Financial Performance| Metric | EQX | ASND |
|---|---|---|
| Price | $14.87 | $242.19 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 16 |
| Target Price | $17.00 | ★ $279.50 |
| AVG Volume (30 Days) | ★ 9.6M | 491.1K |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | ★ 0.10% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $95.14 | $97.60 |
| Revenue Next Year | $11.73 | $43.64 |
| P/E Ratio | $137.41 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.64 | $151.11 |
| 52 Week High | $18.96 | $250.74 |
Technical Indicators
Market Signals| Indicator | EQX | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 51.81 | 58.44 |
| Support Level | $13.54 | $190.49 |
| Resistance Level | $15.31 | $248.60 |
| Average True Range (ATR) | 0.66 | 8.70 |
| MACD | 0.21 | 2.14 |
| Stochastic Oscillator | 78.14 | 75.39 |
Price Performance
Historical ComparisonAbout EQX Equinox Gold Corp.
Equinox Gold Corp is a mining company engaged in the operation, acquisition, exploration, and development of mineral properties, with a focus on gold. Equinox Gold has around seven operating gold mines and a clear plan to increase production by advancing the pipeline of growth projects. Geographically, the company operates in the United States, Mexico, and Brazil. The majority of its revenue is generated from Canada.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.